Full-Time
Hospitalist Nurse Practitioner Oncology Northridge CA
Posted on 3/19/2025
The Oncology Institute of Hope and Innovation
201-500 employees
Provides value-based cancer care in community
Compensation Overview
$160k - $180k/yr
Northridge, Los Angeles, CA, USA
In Person
 Medical, Clinical & Veterinary (2) |
|---|
| , |
- Master's or Doctorate degree in Nursing.
- State licensure as a Nurse Practitioner or Physician Assistant.
- Work at assigned hospital facilities.
- Conduct comprehensive assessments and work with physicians to create evidence-based care plans for oncology patients.
- Collaborate with a multidisciplinary team to ensure holistic and personalized care.
- Administer specialized treatments and interventions under physician supervision.
- Provide education and emotional support to patients and their families.
- Contribute to quality improvement initiatives and collaborative research projects.
- Serve as the practice leader in assigned areas communicating with hospitalists and other specialists to ensure continuity of care.
- Develop strong relationships with hospitalists and other specialists.
- Current certification as an Oncology Nurse Practitioner (AOCNP) or ability to obtain with support from The Oncology Institute.
- 2 years of clinical experience in oncology nursing.
What TOI does: The Oncology Institute of Hope and Innovation operates one of the largest community oncology practices in the United States, offering medical oncology, radiation oncology, and patient support services in a community setting rather than a hospital. How its product works: It uses a value-based care model that focuses on achieving good patient outcomes while managing costs. The institute coordinates oncology services through expert doctors and support teams to provide comprehensive, accessible cancer care, and it has demonstrated savings for Medicare. Who it’s different from: It combines a large, community-based footprint with a clear focus on value and outcomes, delivering coordinated cancer care outside hospital walls unlike many traditional fee-for-service models. What its goal is: to provide compassionate, high-quality cancer care in the community, improving outcomes for patients while controlling costs for individuals and payers.
Company Size
201-500
Company Stage
IPO
Headquarters
Cerritos, California
Founded
2007
Simplify's Take
What believers are saying
- Q4 2025 revenue hit $142M, up 41.6% YoY, with first profitable EBITDA.
- Elevance Florida partnership doubles to 140,000 lives in 2026.
- $16.5M funding secured March 2025 fuels organic growth across five states.
What critics are saying
- OneOncology captures Elevance and Humana lives in Florida within 6 months.
- Stock at $3.08 forces dilution from financings like March 2025 raise.
- US Oncology Network erodes margins with 2,500 providers and drug discounts.
What makes The Oncology Institute of Hope and Innovation unique
- TOI delivers value-based cancer care in community settings since 2007.
- HVCC model reduces costs and hospitalizations, presented at ASCO May 2025.
- Florida Oncology Network launched March 2025 with Provider Network Solutions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%The Oncology Institute has appointed Minh Merchant as Chief Legal Officer. She will oversee legal, regulatory, compliance and privacy functions as the value-based oncology group continues to scale. Merchant brings over 20 years of experience advising public and private healthcare organisations. She previously served as general counsel at Midi Health, Kyverna Therapeutics, Aspira Women's Health and McKesson, and holds a JD from UCLA School of Law. Founded in 2007, The Oncology Institute operates over 100 clinics across five US states, serving approximately 1.9 million patients. The company employs over 180 clinicians and provides cancer care including clinical trials and transfusions in community settings.
The Oncology Institute reported its first profitable quarter on an adjusted EBITDA basis, with Q4 revenue rising 41.6% year-over-year to $142 million. Full-year 2025 revenue exceeded $500 million, up approximately 28%, with adjusted EBITDA of $147,000. Delegated capitation arrangements are driving growth. The Elevance Florida partnership, covering roughly 70,000 lives, is expected to more than double in 2026. Delegated members represent less than 5% of capitated lives but account for approximately one-third of run-rate capitated revenue. The company added around 22,000 Humana Medicare Advantage lives in Q4. Management reaffirmed 2026 guidance of $630–650 million revenue and $0–9 million adjusted EBITDA. The company ended 2025 with $33.6 million cash after reducing convertible preferred debt by $24 million.
The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, has appointed Kristin England as its new Chief Administrative Officer (CAO), effective July 7, 2025.
The Oncology Institute to participate at the B. Riley securities 25th Annual Institutional Investor Conference.
CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) - The Oncology Institute, Inc. (NASDAQ: TOI)("TOI"), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*.